Glucose-dependent changes in SNARE proyein levels in pancreatic beta-cells

dc.contributor.authorTorrejón-Escribano, Benjamín
dc.contributor.authorEscoriza, Jessica
dc.contributor.authorMontanya Mias, Eduard
dc.contributor.authorBlasi Cabús, Joan
dc.date.accessioned2019-05-31T13:06:25Z
dc.date.available2019-05-31T13:06:25Z
dc.date.issued2011-04
dc.date.updated2019-05-31T13:06:25Z
dc.description.abstractProlonged exposure to high glucose concentration alters the expression of a set of proteins in pancreatic-cells and impairs their capacity to secrete insulin. The cellular and molecular mechanisms that lie behind this effect are poorly understood. In this study, three either in vitro or in vivo models (cultured rat pancreatic islets incubated in high glucose media, partially pancreatectomized rats, and islets transplanted to streptozotozin-induced diabetic mice) were used to evaluate the dependence of the biological model and the treatment, together with the cell location (insulin granule or plasma membrane) of the affected proteins and the possible effect of sustained insulin secretion, on the glucose-induced changes in protein expression. In all three models, islets exposed to high glucose concentrations showed a reduced expression of secretory granule associated vesicle-soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins synaptobrevin/ vesicle-associated membrane protein 2 and cellubrevin but minor or no significant changes in the expression of the membrane-associated target-SNARE proteins syntaxin1 and synaptosomal associated protein-25 and a marked increase in the expression of synaptosomal-associated protein-23 protein. The inhibition of insulin secretion by the L-type voltage-dependent calcium channel nifedipine or the potassium channel activator diazoxide prevented the glucoseinduced reduction in islet insulin content but not in vesicle-SNARE proteins, indicating that the granule depletion due to sustained exocytosis was not involved in the changes of protein expression induced by high glucose concentration. Altogether, the results suggest that high glucose has a direct toxic effect on the secretory pathway by decreasing the expression of insulin granule SNARE-associated proteins.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec584596
dc.identifier.issn0013-7227
dc.identifier.pmid21285315
dc.identifier.urihttps://hdl.handle.net/2445/134283
dc.language.isoeng
dc.publisherAssociation for the Study of Internal Secretions
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1210/en.2010-0898
dc.relation.ispartofEndocrinology, 2011, vol. 152, num. 4, p. 1290-1299
dc.relation.urihttps://doi.org/10.1210/en.2010-0898
dc.rights(c) Association for the Study of Internal Secretions, 2011
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationGlucosa
dc.subject.classificationFarmacologia
dc.subject.classificationInsulina
dc.subject.classificationFarmacocinètica
dc.subject.classificationMetabolisme
dc.subject.classificationProteïnes SNARE
dc.subject.classificationCèl·lules B
dc.subject.otherGlucose
dc.subject.otherPharmacology
dc.subject.otherInsulin
dc.subject.otherPharmacokinetics
dc.subject.otherMetabolism
dc.subject.otherSNARE Proteins
dc.subject.otherB cells
dc.titleGlucose-dependent changes in SNARE proyein levels in pancreatic beta-cells
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
584596.pdf
Mida:
2.34 MB
Format:
Adobe Portable Document Format